Two cases of drug-induced psoriasis from second-generation androgen receptor blockers
We present here two cases of androgen receptor-induced psoriasis. Both cases ultimately continued their medications after risk/benefit analysis by multidisciplinary teams. Both cases also improved with topical ultrapotent steroids. To our knowledge, this is the first case series reported to show androgen receptor inhibitors implicated as a class in psoriatic drug eruptions.
Authors
- Darren E. Whittemore
- Carsten R. Hamann (ORCID: https://orcid.org/0000-0003-2011-7380)
- Dathan Hamann (ORCID: https://orcid.org/0000-0003-2052-3725)
- Amber Flaherty
- Guy Charest
- Ben Buttars
- Dave Baltazar
Institutions
- Dartmouth–Hitchcock Medical Center (US)
- City of Hope (US)
- HonorHealth (US)
- Dermatology Specialists (US)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1093/ced/llae509
- Citations
- 2
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.90